Increased insurance coverage should boost demand for medical services which would highlight concerns about access to medical care, particularly outside of Boston.
Increased insurance coverage should boost demand for medical services which would highlight concerns about access to medical care, particularly outside of Boston.
"Rural areas tend to have a higher percentage of poor and uninsured and fewer doctors. Insurance alone may not assure access," according to B. Dale Magee, MD, MS, president of the Massachusetts Medical Society.
A shortage of primary care physicians in Massachusetts has led many doctors to stop accepting new patients, according to a recent report by the Massachusetts Medical Society. "Primary care physicians should be central to the delivery of healthcare," Dr. Magee says. "Absent a primary care physician, patients tend to distribute their care among specialists, which can lead to more testing and less continuity and drive up expenses. Distribution of physicians-both within the state and the country-is part of the issue and we need to be cognizant of the fact that physicians have choices in where they can live. Incentives to practice in underserved areas need to be more effective. Some specialties, such as primary care, should be compensated in a manner that recognizes their importance. In that end, the financial consequences of a primary care shortage may cost more than appropriate compensation."
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More